{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:01:48Z","timestamp":1792638108058,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["XWKYHT20240050"],"award-info":[{"award-number":["XWKYHT20240050"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["XWKYHT20240047"],"award-info":[{"award-number":["XWKYHT20240047"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["XWRCHT20220006"],"award-info":[{"award-number":["XWRCHT20220006"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["XYFM202413"],"award-info":[{"award-number":["XYFM202413"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["XYFM202414"],"award-info":[{"award-number":["XYFM202414"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.imlet.2025.107122","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:32:38Z","timestamp":1764808358000},"page":"107122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Lenvatinib-resistant liver cancer-derived HSP90\u03b1-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion"],"prefix":"10.1016","volume":"278","author":[{"given":"Xin-Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7961-2485","authenticated-orcid":false,"given":"Yong-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.imlet.2025.107122_bib0001","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.imlet.2025.107122_bib0002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"issue":"3","key":"10.1016\/j.imlet.2025.107122_bib0003","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","article-title":"Advances in the early diagnosis of hepatocellular carcinoma","volume":"7","author":"Wang","year":"2020","journal-title":"Genes. Dis."},{"key":"10.1016\/j.imlet.2025.107122_bib0004","doi-asserted-by":"crossref","unstructured":"Cucarull B., A. Tutusaus, P. Rider, T. Hern\u00e1ez-Alsina, C. Cu\u00f1o, P. Garc\u00eda de Frutos, et al. Hepatocellular carcinoma: molecular pathogenesis and therapeutic advances.Cancers (Basel). 2022. 14(3)doi:10.3390\/cancers14030621.","DOI":"10.3390\/cancers14030621"},{"issue":"1","key":"10.1016\/j.imlet.2025.107122_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primer."},{"key":"10.1016\/j.imlet.2025.107122_bib0006","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/JHC.S285726","article-title":"Elucidating the molecular basis of Sorafenib resistance in HCC: current findings and future directions","volume":"8","author":"Fornari","year":"2021","journal-title":"J. Hepatocell. Carcinom."},{"issue":"8","key":"10.1016\/j.imlet.2025.107122_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081959","article-title":"Mesenchymal stem cell-derived exosomes: applications in regenerative medicine","volume":"10","author":"Hade","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.imlet.2025.107122_bib0008","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jhep.2021.12.005","article-title":"Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma","volume":"76","author":"Tey","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2025.107122_bib0009","article-title":"Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review","volume":"11","author":"Wang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"14","key":"10.1016\/j.imlet.2025.107122_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141879","article-title":"Roles of extracellular vesicles on the progression and metastasis of hepatocellular carcinoma","volume":"12","author":"Seay","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.imlet.2025.107122_bib0011","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: from mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun. (Lond)"},{"issue":"5","key":"10.1016\/j.imlet.2025.107122_bib0012","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of chemokines in the crosstalk between tumor and tumor-associated macrophages","volume":"23","author":"Qin","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"5","key":"10.1016\/j.imlet.2025.107122_bib0013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2016.10.013","article-title":"Unraveling the DNA methylome in mantle cell lymphoma: new insights into the cellular origin","volume":"30","author":"Mansouri","year":"2016","journal-title":"Cancer Cell"},{"issue":"26","key":"10.1016\/j.imlet.2025.107122_bib0014","doi-asserted-by":"crossref","first-page":"22880","DOI":"10.18632\/oncotarget.4412","article-title":"Co-expression of CXCL8 and HIF-1\u03b1 is associated with metastasis and poor prognosis in hepatocellular carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.imlet.2025.107122_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2019.03.012","article-title":"Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines","volume":"119","author":"Peng","year":"2019","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.imlet.2025.107122_bib0016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13046-019-1455-x","article-title":"Interleukin-8 promotes integrin \u03b23 upregulation and cell invasion through PI3K\/Akt pathway in hepatocellular carcinoma","volume":"38","author":"Sun","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.imlet.2025.107122_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.imlet.2025.107122_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108760","article-title":"Evaluation of plasma LC3B(+)extracellular vesicles as a potential novel diagnostic marker for hepatocellular carcinoma","volume":"108","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2025.107122_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109925","article-title":"Tumor cell-derived LC3B(+)extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90\u03b1-IL-6\/IL-8 signaling axis","volume":"261","author":"Chen","year":"2024","journal-title":"Clin. Immunol."},{"issue":"20","key":"10.1016\/j.imlet.2025.107122_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011018","article-title":"ANXA1 Contained in EVs regulates macrophage polarization in tumor microenvironment and promotes pancreatic cancer progression and metastasis","volume":"22","author":"Novizio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.imlet.2025.107122_bib0021","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1158\/0008-5472.CAN-20-3150","article-title":"Targeting the extracellular HSP90 Co-chaperone Morgana inhibits cancer cell migration and promotes anticancer immunity","volume":"81","author":"Secl\u00ec","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.imlet.2025.107122_bib0022","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s40425-019-0646-5","article-title":"Tumor-released autophagosomes induces CD4(+) T cell-mediated immunosuppression via a TLR2-IL-6 cascade","volume":"7","author":"Chen","year":"2019","journal-title":"J. Immunother Cancer"},{"key":"10.1016\/j.imlet.2025.107122_bib0023","article-title":"Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.imlet.2025.107122_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100976","article-title":"Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression","volume":"69","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"9","key":"10.1016\/j.imlet.2025.107122_bib0025","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.7150\/ijbs.96031","article-title":"Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1\/2 axis in hepatocellular carcinoma","volume":"20","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2025.107122_bib0026","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1038\/s41598-022-12076-w","article-title":"EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells","volume":"12","author":"He","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2025.107122_bib0027","first-page":"177","article-title":"Interferon-\u03b1 induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion","author":"Ma","year":"2024","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.imlet.2025.107122_bib0028","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ijo.2014.2761","article-title":"Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2\/STAT3\/snail pathway","volume":"46","author":"Fu","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.imlet.2025.107122_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1440166","article-title":"Neurotensin\/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells","volume":"7","author":"Xiao","year":"2018","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.imlet.2025.107122_bib0030","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1002\/jcp.29776","article-title":"The role of HSP90 molecular chaperones in hepatocellular carcinoma","volume":"235","author":"Nouri-Vaskeh","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107122_bib0031","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12885-019-6489-0","article-title":"Diagnostic value of plasma HSP90\u03b1 levels for detection of hepatocellular carcinoma","volume":"20","author":"Wei","year":"2020","journal-title":"BMC Cancer"},{"issue":"Pt A","key":"10.1016\/j.imlet.2025.107122_bib0032","article-title":"Mechanism of M2 type macrophage-derived extracellular vesicles regulating PD-L1 expression via the MISP\/IQGAP1 axis in hepatocellular carcinoma immunotherapy resistance","volume":"124","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107122_bib0033","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12935-023-02980-0","article-title":"Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.imlet.2025.107122_bib0034","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1515\/hsz-2020-0328","article-title":"C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)","volume":"402","author":"Wan","year":"2021","journal-title":"Biol. Chem."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:44:53Z","timestamp":1773870293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"alternative-id":["S0165247825001555"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107122","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenvatinib-resistant liver cancer-derived HSP90\u03b1-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107122"}}